ClinConnect ClinConnect Logo
Search / Trial NCT01204281

Proportional Assist Ventilation (PAV) in Early Stage of Critically Ill Patients

Launched by ALTHAIA XARXA ASSISTENCIAL UNIVERSITÀRIA DE MANRESA · Sep 16, 2010

Trial Information

Current as of August 24, 2025

Completed

Keywords

Proportional Assist Ventilation Plus Acute Respiratory Failure Mechanical Ventilation

ClinConnect Summary

The goal of this proposal is to apply PAV+ as routine ventilatory mode in the early stage of critically ill patients, taking advantages of spontaneous breathing and better patient-ventilator interaction.

The standard treatment in patients with acute respiratory failure is mechanical ventilation in control-mode for the first days of acute illness. This procedure is usually associated with patient-ventilator dyssynchrony, higher needs of sedation and/or relaxation, muscle atrophy, etc. PAV + is a new ventilatory mode that applies pressure in proportion to spontaneous patient inspiratory effo...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Patients 18 years of age or older
  • Anticipated MV \> 24 hours
  • Availability of informed consent from patient or next of kin
  • * Ventilation parameters measured under PAV+ 80% gain:
  • PaO2/FiO2 \>100 RPAV \<10 cm H2O/l/s CPAV \> 30 ml/cm H2O WOBTOT \<1.5 J/l VE \<18 l/min
  • Exclusion Criteria:
  • Patients on moribund state or with life-sustaining therapy withholding decision.
  • Patients with unstable respiratory/hemodynamic state, PaO2/FiO2 \<100, Dopamine \>15 microg/Kg/min or epinephrine \>0.1 microg/kg/min.
  • Pregnancy.
  • Air leak.
  • Patients needing deep sedation or muscle paralysis
  • Patients needing hyperventilation (brain trauma).
  • Patients with severe muscle weakness.
  • Recruitment maneuvers or prone position.

About Althaia Xarxa Assistencial Universitària De Manresa

Althaia Xarxa Assistencial Universitària de Manresa is a leading healthcare institution in Catalonia, Spain, dedicated to providing high-quality medical care and advancing clinical research. As a university-affiliated network, Althaia integrates comprehensive healthcare services with academic excellence, fostering innovation and collaboration in the medical field. The organization is committed to improving patient outcomes through rigorous clinical trials and research initiatives, focusing on a wide range of therapeutic areas. With a multidisciplinary team of healthcare professionals, Althaia plays a pivotal role in enhancing evidence-based practices and contributing to the global medical community.

Locations

Manresa, Catalunya, Spain

Patients applied

0 patients applied

Trial Officials

Rafael Fernandez, M.D.

Principal Investigator

Althaia Xarxa Assistencial Universitària de Manresa

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials